SMMT logo

Summit Therapeutics Inc. (SMMT) Shareholders equity

annual shareholders equity:

$388.75M+$311.06M(+400.37%)
December 31, 2024

Summary

  • As of today (August 31, 2025), SMMT annual stockholders equity is $388.75 million, with the most recent change of +$311.06 million (+400.37%) on December 31, 2024.
  • During the last 3 years, SMMT annual shareholders equity has risen by +$305.46 million (+366.77%).
  • SMMT annual shareholders equity is now at all-time high.

Performance

SMMT Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTbalance sheet metrics

quarterly shareholders equity:

$259.44M-$84.89M(-24.65%)
June 30, 2025

Summary

  • As of today (August 31, 2025), SMMT quarterly stockholders equity is $259.44 million, with the most recent change of -$84.89 million (-24.65%) on June 30, 2025.
  • Over the past year, SMMT quarterly shareholders equity has increased by +$64.36 million (+32.99%).
  • SMMT quarterly shareholders equity is now -40.76% below its all-time high of $437.92 million, reached on September 30, 2024.

Performance

SMMT quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SMMT Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+400.4%+33.0%
3 y3 years+366.8%+405.6%
5 y5 years+395.5%-

SMMT Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+400.4%-40.8%+486.8%
5 y5-yearat high+400.4%-40.8%+603.8%
alltimeall timeat high+8685.8%-40.8%+2613.3%

SMMT Shareholders equity History

DateAnnualQuarterly
Jun 2025
-
$259.44M(-24.7%)
Mar 2025
-
$344.33M(-11.4%)
Dec 2024
$388.75M(+400.4%)
$388.75M(-11.2%)
Sep 2024
-
$437.92M(+124.5%)
Jun 2024
-
$195.07M(+341.2%)
Mar 2024
-
$44.21M(-43.1%)
Dec 2023
$77.69M(-38.7%)
$77.69M(-21.8%)
Sep 2023
-
$99.38M(-16.9%)
Jun 2023
-
$119.60M(-10.4%)
Mar 2023
-
$133.48M(+5.4%)
Dec 2022
$126.65M(+52.1%)
$126.65M(-4.9%)
Sep 2022
-
$133.25M(+159.7%)
Jun 2022
-
$51.32M(-20.3%)
Mar 2022
-
$64.41M(-22.7%)
Dec 2021
$83.28M(+4.8%)
$83.28M(-18.6%)
Sep 2021
-
$102.30M(-14.3%)
Jun 2021
-
$119.43M(+85.4%)
Mar 2021
-
$64.41M(-18.9%)
Dec 2020
$79.45M(+1.3%)
-
Dec 2020
-
$79.45M(+115.5%)
Sep 2020
-
$36.86M(-45.5%)
Mar 2020
-
$67.62M(+20.8%)
Dec 2019
$78.46M(-1832.8%)
-
Jan 2019
-
$55.96M(+56.2%)
Oct 2018
-
$35.82M(-17.4%)
Jul 2018
-
$43.36M(-26.0%)
Apr 2018
-
$58.59M(-1394.0%)
Jan 2018
-$4.53M(+3.0%)
-
Jan 2018
-
-$4.53M(-121.2%)
Oct 2017
-
$21.39M(+363.5%)
Jul 2017
-
$4.61M(-144.7%)
Apr 2017
-
-$10.32M(+134.9%)
Jan 2017
-$4.39M(-119.3%)
-
Jan 2017
-
-$4.39M(-430.5%)
Oct 2016
-
$1.33M(-90.5%)
Jul 2016
-
$14.03M(-41.3%)
Apr 2016
-
$23.92M(-20.2%)
Jan 2016
$22.81M
-
DateAnnualQuarterly
Jan 2016
-
$29.98M(-25.1%)
Oct 2015
-
$40.02M(-15.1%)
Jul 2015
-
$47.15M(-9.4%)
Apr 2015
-
$52.05M(+131.6%)
Jan 2015
$22.48M(+187.2%)
-
Jan 2015
-
$22.48M(-20.4%)
Oct 2014
-
$28.25M(-16.5%)
Jul 2014
-
$33.82M(+330.5%)
Jan 2014
$7.83M(+73.1%)
-
Jan 2014
-
$7.86M(-1.9%)
Jul 2013
-
$8.01M(+77.8%)
Jan 2013
$4.52M(+19.1%)
-
Jan 2013
-
$4.50M(-40.0%)
Jul 2012
-
$7.51M(+98.7%)
Jan 2012
$3.80M(-35.6%)
-
Jan 2012
-
$3.78M(-34.5%)
Jul 2011
-
$5.77M(-0.9%)
Jan 2011
$5.89M(-55.6%)
-
Jan 2011
-
$5.82M(-43.3%)
Jul 2010
-
$10.27M(-22.3%)
Jan 2010
$13.26M(+7.6%)
-
Jan 2010
-
$13.22M(+40.6%)
Jul 2009
-
$9.41M(-23.7%)
Jan 2009
$12.33M(-77.2%)
-
Jan 2009
-
$12.33M(-73.9%)
Jul 2008
-
$47.29M(-12.6%)
Jan 2008
$54.07M(+35.1%)
-
Jan 2008
-
$54.08M(-17.8%)
Jul 2007
-
$65.79M(+64.0%)
Jan 2007
$40.03M(+72.0%)
-
Jan 2007
-
$40.11M(-2.7%)
Jul 2006
-
$41.21M(+76.3%)
Jan 2006
$23.27M(-12.4%)
-
Jan 2006
-
$23.38M(-4.6%)
Jul 2005
-
$24.51M(-7.6%)
Jan 2005
$26.57M(>+9900.0%)
-
Jan 2005
-
$26.53M(<-9900.0%)
Jul 2004
-
-$32.80K
Jan 2004
$47.80K
-

FAQ

  • What is Summit Therapeutics Inc. annual stockholders equity?
  • What is the all time high annual shareholders equity for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. annual shareholders equity year-on-year change?
  • What is Summit Therapeutics Inc. quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Summit Therapeutics Inc.?
  • What is Summit Therapeutics Inc. quarterly shareholders equity year-on-year change?

What is Summit Therapeutics Inc. annual stockholders equity?

The current annual shareholders equity of SMMT is $388.75M

What is the all time high annual shareholders equity for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high annual stockholders equity is $388.75M

What is Summit Therapeutics Inc. annual shareholders equity year-on-year change?

Over the past year, SMMT annual stockholders equity has changed by +$311.06M (+400.37%)

What is Summit Therapeutics Inc. quarterly stockholders equity?

The current quarterly shareholders equity of SMMT is $259.44M

What is the all time high quarterly shareholders equity for Summit Therapeutics Inc.?

Summit Therapeutics Inc. all-time high quarterly stockholders equity is $437.92M

What is Summit Therapeutics Inc. quarterly shareholders equity year-on-year change?

Over the past year, SMMT quarterly stockholders equity has changed by +$64.36M (+32.99%)
On this page